The latest AAC update for August provides useful information which may be of benefit to member companies:
Funding for innovations and community collaborations
The National Institute for Heath and Care Research (NIHR) is offering to fund up to £150k partnerships between research teams, community, and charity organisations to develop enduring health and social care research collaborations that will aide researchers in providing better solutions for individual communities. Please share this with your networks by 21 September to encourage applications.
The next round of the NHS Innovation Accelerator opens on 1st September. The NHS Innovation Accelerator (NIA) supports exceptional individuals to scale promising innovations across the NHS. This includes a bespoke learning programme, mentorship and networking opportunities to equip innovators with the knowledge, relationships and skills to scale innovation in the NHS. Please direct interested applicants to the NIA application portal for more information.
Small Business Research Initiatives (SBRI) Healthcare, a collaboration between the AAC and the Academic Health Science Network, has launched the second net zero funding competition in partnership with the Greener NHS team. This is seeking innovations that can help reduce carbon emissions in clinical care while delivering high quality patient care. Please share the competition page with anyone interested from public, private and third sectors including companies, charities, universities and NHS organisations.
Supporting research and evaluation
The National Contract Value Review (NCVR) is a standardised, national approach to costing commercial research. From October 2022 the NCVR will begin to replace the current process and help accelerate the time it takes to set up commercial contracts. Find out more about what the process on our website. This is good news for industry, and we invite AAC members to spread the news among commercial research companies.
Please take part in and share the Department of Health & Social Care’s Equity in medical devices: independent review call for evidence. The review is gathering evidence on how medical devices and technologies may be biased against patients of different ethnicities, genders and other socio-demographic groups until 6 October 2022.